Biological specimen evaluation methods using cytology and immunology
US9880156B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2014 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Aug 15, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7095
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Information on cytokines and cytology obtained from a biological specimen are combined as a method of predicting the risk that dysplasia will progress to cancer. Methods are disclosed herein to augment the evaluation of biological samples from subjects being tested for cancer. In addition to the cell types that are traditionally considered in the morphology-based cytological screening of specimens, methods disclosed herein add evaluations of certain cell types and cytokines that are traditionally discounted or ignored during screening.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.